Clinical and prognostic significance of bendopnea in elderly outpatients

Clinical and prognostic significance of bendopnea in elderly outpatients

Aim. To assess clinical and prognostic significance of dyspnea when leaning forward in elderly outpatients.Material and methods. The open, prospective, non-randomized study included 55 outpatients >60 years old with class II-IV (NYHA) chronic heart failure (CHF) as a result of coronary artery...

Full description

Bibliographic Details
Main Authors:	V. N. Larina, M. G. Golovko, M. I. Zakharova, N. L. Bogush, G. V. Poryadin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2019-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	одышка бендопноэ хроническая сердечная недостаточность пожилые пациенты
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2296

Similar Items

Russian National Research Medical University named after N.I. Pirogov, Moscow
by: V. N. Larina, et al.
Published: (2015-09-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

MODERN VIEW OF CARDIOPULMONARY EXERCISE TESTING (REVIEW OF ACR/EULAR GUIDELINES, 2016)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

Respiratory Muscles Training in the Complex Treatment of Patients with Acute Decompensated Heart Failure
by: N. T. Vatutin, et al.
Published: (2022-02-01)

Клинические особенности хронической обструктивной болезни легких у пожилых людей.
by: Nicolae BODRUG, et al.
Published: (2021-11-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Роль физических упражнений в механизмах прогрессирования хронической сердечной недостаточности у больных ишемической болезнью сердца пожилого возраста
by: Ольга Александровна Осипова, et al.
Published: (2020-12-01)

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2017-12-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

Echocardiographic characteristics of patients with ischemic and non-ischemic chronic heart failure with reduced ejection fraction
by: N. N. Ilov, et al.
Published: (2022-10-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
by: A. G. Kuzmin, et al.
Published: (2014-08-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

Depressive disorders in elderly patients with heart failure disease
by: I. V. Osipova, et al.
Published: (2007-12-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

Physical training – modulator of peripheral factors for chronic heart failure development
by: A. S. Noskova, et al.
Published: (2007-02-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE
by: N. Yu Borovkova, et al.
Published: (2016-12-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Hypertensive encephalopathy, heart remodeling, and chronic heart failure
by: L. A. Geraskina, et al.
Published: (2006-06-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Prognostic algorithms for the progression of chronic heart failure depending on the clinical phenotype
by: E. A. Polunina, et al.
Published: (2019-06-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Patient compliance and physicians’ adherence to guidelines on heart failure with reduced ejection fraction
by: V. N. Larina, et al.
Published: (2020-04-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Levels of angiogenesis markers in patients with different heart failure phenotypes
by: R. N. Shepel, et al.
Published: (2022-03-01)

Alternative Options for the Nutritional Status of Patients with Chronic Heart Failure: CHF Phenotype with Sarcopenic Obesity
by: V. I. Shevtsova, et al.
Published: (2021-11-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)